340B Accountability Act of 2023
Source: Congress.gov ·
313 words in original text
What This Bill Does
This bill amends a federal health law to clarify rules about drug discounts that certain healthcare organizations receive. It adds new requirements for how these organizations must track and report their spending from these discounts.
##
Who It Affects
Covered entities (healthcare organizations that receive drug discounts under federal law), the Secretary of Health and Human Services, and drug manufacturers.
##
Key Provisions
• Covered entities must allow the Secretary to audit their records to determine how they use the money they save from buying discounted drugs. The Secretary pays for these audits. (Sec. 2)
• Covered entities must keep records and provide reports that the Secretary decides are necessary to carry out these audit and tracking requirements. (Sec. 2)
##
What Changes
If this bill becomes law, covered entities will be subject to audits of how they spend money saved from discounted drug purchases, and they must keep detailed records available for the Secretary to review.
##
Important Definitions
None defined in this bill text.
##
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.